Literature DB >> 18027911

Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2.

Hana Schmeisser1, Inna Gorshkova, Patrick H Brown, Peter Kontsek, Peter Schuck, Kathryn C Zoon.   

Abstract

The interaction between two human interferons alpha (IFN-alphas) and the extracellular (EC) domain of human type I IFN receptor subunit 2 (IFNAR2) was analyzed. Previous experiments using Daudi cells showed that IFN-alpha21b and some IFN-alpha hybrids (made from IFN-alpha2c and 21b) competed poorly for the IFN-alpha2b binding site. This study examined the causes of the poor competition between these IFN-alphas. IFN-alpha2c and the IFN hybrid CM3 {IFN-alpha21b(1-75)(81-95)/IFN-alpha2c(76-80) (96-166), Y86K} were selected for this study based on their cell binding and biological properties. Competitive binding ELISA, native electrophoresis followed by Western blot, electrospray ionization mass spectrometry (ESI-MS), surface plasmon resonance biosensor (SPR) analysis, as well as neutralization of antiproliferative activities on Daudi cells in the presence of soluble IFNAR2-EC show evidence that each of the described IFN-alpha subtypes affected the binding of the other IFN-alpha to IFNAR2-EC by affecting the stability of the complex, i.e., dissociation of the complex. Moreover, native electrophoresis with different IFNAR2-EC mutants showed that IFN-alpha2c and CM3 utilize different amino acids in the binding domain of IFNAR2-EC. In addition to that, analytical ultracentrifugation (AUC) revealed differences in the oligomeric state of the two studied interferons. Our results demonstrated that two individual IFN-alphas interact differentially with IFNAR2-EC and influence each other during this interaction. This study contributes to the understanding of the mutual interaction between multiple IFN-alpha subtypes during the competition for binding to the receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18027911      PMCID: PMC2570179          DOI: 10.1021/bi7012036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria.

Authors:  Juraj Svitel; Andrea Balbo; Roy A Mariuzza; Noreen R Gonzales; Peter Schuck
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

2.  Purification and characterization of multiple components of human lymphoblastoid interferon-alpha.

Authors:  K C Zoon; D Miller; J Bekisz; D zur Nedden; J C Enterline; N Y Nguyen; R Q Hu
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

3.  Mapping of an epitope of human leukocyte alpha interferon A which is recognized by the murine monoclonal antibody NK2.

Authors:  A P Alexenko; L S Izotova; S V Kostrov
Journal:  Biomed Sci       Date:  1991

Review 4.  The human interferons--from protein purification and sequence to cloning and expression in bacteria: before, between, and beyond.

Authors:  S Pestka
Journal:  Arch Biochem Biophys       Date:  1983-02-15       Impact factor: 4.013

5.  Physicochemical and antigenic properties of synthetic fragments of human leukocyte interferon.

Authors:  H Arnheiter; R M Thomas; T Leist; M Fountoulakis; B Gutte
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

6.  Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.

Authors:  Chantal Cajean-Feroldi; Florence Nosal; Pierre C Nardeux; Xavier Gallet; Jacqueline Guymarho; Florence Baychelier; Pascal Sempé; Michael G Tovey; Jean-Louis Escary; Pierre Eid
Journal:  Biochemistry       Date:  2004-10-05       Impact factor: 3.162

7.  Immunodominant structures in the aminoterminal portion of human interferon alpha 1.

Authors:  P Kontsek; L Borecký; E Kontseková; A Kolcunová; M Novák; V P Zav'yalov; V A Maiorov
Journal:  Mol Immunol       Date:  1992 Jul-Aug       Impact factor: 4.407

8.  Automated, quantitative cytopathic effect reduction assay for interferon.

Authors:  T J Yeh; P T McBride; J C Overall; J A Green
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

9.  Optimizing the binding affinity of a carrier protein: a case study on the interaction between soluble ifnar2 and interferon beta.

Authors:  Tal Peleg-Shulman; Laila C Roisman; Gordin Zupkovitz; Gideon Schreiber
Journal:  J Biol Chem       Date:  2004-02-11       Impact factor: 5.157

Review 10.  The human interferon system: characterization and classification after discovery of novel members.

Authors:  P Kontsek; G Karayianni-Vasconcelos; E Kontseková
Journal:  Acta Virol       Date:  2003       Impact factor: 1.162

View more
  3 in total

1.  Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.

Authors:  Corey A Balinsky; Hana Schmeisser; Sundar Ganesan; Kavita Singh; Theodore C Pierson; Kathryn C Zoon
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 2.  Using Lamm-Equation modeling of sedimentation velocity data to determine the kinetic and thermodynamic properties of macromolecular interactions.

Authors:  Chad A Brautigam
Journal:  Methods       Date:  2010-12-25       Impact factor: 3.608

3.  Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene.

Authors:  H Schmeisser; J Mejido; C A Balinsky; A N Morrow; C R Clark; T Zhao; K C Zoon
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.